Live Breaking News & Updates on Biopharmaceutical Services

Stay updated with breaking news from Biopharmaceutical services. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Transcripts For CNBC Power 20240703

Yesterday. Boosted by earnings by microsoft and especially google. Alphabet up more than 10 today, as you see right there well have more on those results coming. And what were seeing here is that todays game is really pushing alphabet into the 2 million market cap along with microsoft and nvidia all the major averages set to end this week with gains the nasdaq up more than 4 you can see that big drop yesterday morning and then that steady rebound yesterday and into todays session well keep our eye on that, tyler. All right lets start with a number helping to clear the way for this rally after yesterdays worrying gdp report. The markets seemed to like what they saw in this mornings pce thats an inflation number steve joins us now with a little bit more what did they like and you started to explain this in the last hour or two, and id love to hear you continue. What is the difference between pce and cpi and all these other different ....

Market Cap , Big Drop , Consumer Price , Price Index , Like Service , First Quarter , Basis Points , Rearview Mirror , Just Bad , Inflation Numbers , High Side , Growth Numbers , Push Pull , Ceo Strategy , Strategy Asset Managers , Asset Managers , Interest Rate , Strong Economy , Labor Market , Investment Opportunities , Savings Rates , Interest Rates , Going Technology , Health Care , Pricing Power , Larger Holdings ,

Biodesix, Inc. (NASDAQ:BDSX) Q1 2024 Earnings Call Transcript

Biodesix, Inc. (NASDAQ:BDSX) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

United States , Kyle Mikson , Robin Harper Cowie , Scott Hutton , William Blair , Chris Brinzey , Gary Pestano , Canaccord Genuity , Andrew Brackmann , Howard Scher , Friends Of Cancer Research , Biopharma Services , International Precision Medicine , Biodesix Inc , American Association For Cancer Research Annual Meeting , Exchange Commission , Biopharmaceutical Services , Biopharmaceutical Service , Memorial Sloan Kettering Cancer Center , Call Transcript May , Chief Executive , Chief Financial , Investor Relations , Risk Factors , Annual Report , Lung Diagnostic ,

Biodesix Announces First Quarter 2024 Results Driven by Growth in Lung Diagnostic Testing for Lung Nodule Management

Biodesix Announces First Quarter 2024 Results Driven by Growth in Lung Diagnostic Testing for Lung Nodule Management
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United States , Scott Hutton , Memorial Sloan Kettering Cancer Center , Biodesix Inc , American Association For Cancer Research , Biopharmaceutical Services , Announces First Quarter , Lung Diagnostic Testing , Lung Nodule , Net Loss , American Association , Cancer Research , Annual Meeting , Lung Diagnostics , Lung Diagnostic , Integrated Diagnostics , Nodify Lung , Nodule Risk Assessment , Private Securities Litigation Reform Act , Risk Factors , Balance Sheets , Months Ended March ,

Biodesix Announces Fourth Quarter and Fiscal Year 2023 Results and Business Highlights

Persistent, high double-digit growth in Lung Diagnostic test volume - growing 65% in FY2023 versus FY2022 - and the sixth consecutive quarter with greater than 50% year-over-year growth;

Ongoing. ....

United States , Scott Hutton , Biopharma Services , Biodesix Inc , Biopharmaceutical Services , Lung Diagnostic , Full Year , Nodify Lung , Nodule Risk Assessment , Perceptive Advisors , Investors Page , Diagnostic Cortex , Artificial Intelligence , Private Securities Litigation Reform Act , Risk Factors , Balance Sheets , Months Ended December , Ended December , Net Loss ,

Biodesix, Inc. (NASDAQ:BDSX) Q2 2023 Earnings Call Transcript

Biodesix, Inc. (NASDAQ:BDSX) Q2 2023 Earnings Call Transcript August 7, 2023 Biodesix, Inc. misses on earnings expectations. Reported EPS is $-0.17013 EPS, expectations were $0.21. Operator: Good day and thank you for standing by. Welcome to the Biodesix Second Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. After […] ....

United States , Scott Hutton , Robin Harper Cowie , Biopharmaceutical Services , Harper Cowie , Integrated Diagnostics , Collection Kit , Gold Mining Stocks To Buy , Diagnostic Test , Diagnostic Testing , Lung Nodules , Scott Hutton , Robin Harper Cowie ,